世界のHER2抗体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global HER2 Antibodies Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2800
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、HER2抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（トラスツズマブ、ラパチニブ、アド-トラスツズマブエムタンシン、ペルツズマブ、エベロリムス）、用途別市場規模（病院薬局、小売薬局、Eコマース）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・HER2抗体の市場動向
・企業の競争状況、市場シェア
・HER2抗体の種類別市場規模（トラスツズマブ、ラパチニブ、アド-トラスツズマブエムタンシン、ペルツズマブ、エベロリムス）
・HER2抗体の用途別市場規模（病院薬局、小売薬局、Eコマース）
・HER2抗体の北米市場規模2016-2027（アメリカ、カナダ）
・HER2抗体のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・HER2抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・HER2抗体の中南米市場規模2016-2027（メキシコ、ブラジル）
・HER2抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis、Pfizer、Roche、Abnova、InvivoGen、Celltrion、Biocon、Novus Biologicals）
・結論

The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer.

Market Analysis and Insights: Global HER2 Antibodies Market
The global HER2 Antibodies market size is projected to reach US$ 11440 million by 2026, from US$ 8106.1 million in 2019, at a CAGR of 5.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global HER2 Antibodies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global HER2 Antibodies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global HER2 Antibodies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global HER2 Antibodies market.

Global HER2 Antibodies Scope and Market Size
HER2 Antibodies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global HER2 Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Trastuzumab
Lapatinib
Ado-trastuzumab emtansine
Pertuzumab
Everolimus

Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-commerce

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Pfizer
Roche
Abnova
InvivoGen
Celltrion
Biocon
Novus Biologicals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 Antibodies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Trastuzumab
1.2.3 Lapatinib
1.2.4 Ado-trastuzumab emtansine
1.2.5 Pertuzumab
1.2.6 Everolimus
1.3 Market by Application
1.3.1 Global HER2 Antibodies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global HER2 Antibodies Market Perspective (2016-2027)
2.2 HER2 Antibodies Growth Trends by Regions
2.2.1 HER2 Antibodies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 HER2 Antibodies Historic Market Share by Regions (2016-2021)
2.2.3 HER2 Antibodies Forecasted Market Size by Regions (2022-2027)
2.3 HER2 Antibodies Industry Dynamic
2.3.1 HER2 Antibodies Market Trends
2.3.2 HER2 Antibodies Market Drivers
2.3.3 HER2 Antibodies Market Challenges
2.3.4 HER2 Antibodies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top HER2 Antibodies Players by Revenue
3.1.1 Global Top HER2 Antibodies Players by Revenue (2016-2021)
3.1.2 Global HER2 Antibodies Revenue Market Share by Players (2016-2021)
3.2 Global HER2 Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by HER2 Antibodies Revenue
3.4 Global HER2 Antibodies Market Concentration Ratio
3.4.1 Global HER2 Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 Antibodies Revenue in 2020
3.5 HER2 Antibodies Key Players Head office and Area Served
3.6 Key Players HER2 Antibodies Product Solution and Service
3.7 Date of Enter into HER2 Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 HER2 Antibodies Breakdown Data by Type
4.1 Global HER2 Antibodies Historic Market Size by Type (2016-2021)
4.2 Global HER2 Antibodies Forecasted Market Size by Type (2022-2027)

5 HER2 Antibodies Breakdown Data by Application
5.1 Global HER2 Antibodies Historic Market Size by Application (2016-2021)
5.2 Global HER2 Antibodies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America HER2 Antibodies Market Size (2016-2027)
6.2 North America HER2 Antibodies Market Size by Type
6.2.1 North America HER2 Antibodies Market Size by Type (2016-2021)
6.2.2 North America HER2 Antibodies Market Size by Type (2022-2027)
6.2.3 North America HER2 Antibodies Market Size by Type (2016-2027)
6.3 North America HER2 Antibodies Market Size by Application
6.3.1 North America HER2 Antibodies Market Size by Application (2016-2021)
6.3.2 North America HER2 Antibodies Market Size by Application (2022-2027)
6.3.3 North America HER2 Antibodies Market Size by Application (2016-2027)
6.4 North America HER2 Antibodies Market Size by Country
6.4.1 North America HER2 Antibodies Market Size by Country (2016-2021)
6.4.2 North America HER2 Antibodies Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe HER2 Antibodies Market Size (2016-2027)
7.2 Europe HER2 Antibodies Market Size by Type
7.2.1 Europe HER2 Antibodies Market Size by Type (2016-2021)
7.2.2 Europe HER2 Antibodies Market Size by Type (2022-2027)
7.2.3 Europe HER2 Antibodies Market Size by Type (2016-2027)
7.3 Europe HER2 Antibodies Market Size by Application
7.3.1 Europe HER2 Antibodies Market Size by Application (2016-2021)
7.3.2 Europe HER2 Antibodies Market Size by Application (2022-2027)
7.3.3 Europe HER2 Antibodies Market Size by Application (2016-2027)
7.4 Europe HER2 Antibodies Market Size by Country
7.4.1 Europe HER2 Antibodies Market Size by Country (2016-2021)
7.4.2 Europe HER2 Antibodies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific HER2 Antibodies Market Size (2016-2027)
8.2 Asia-Pacific HER2 Antibodies Market Size by Type
8.2.1 Asia-Pacific HER2 Antibodies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific HER2 Antibodies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific HER2 Antibodies Market Size by Type (2016-2027)
8.3 Asia-Pacific HER2 Antibodies Market Size by Application
8.3.1 Asia-Pacific HER2 Antibodies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific HER2 Antibodies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific HER2 Antibodies Market Size by Application (2016-2027)
8.4 Asia-Pacific HER2 Antibodies Market Size by Region
8.4.1 Asia-Pacific HER2 Antibodies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific HER2 Antibodies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America HER2 Antibodies Market Size (2016-2027)
9.2 Latin America HER2 Antibodies Market Size by Type
9.2.1 Latin America HER2 Antibodies Market Size by Type (2016-2021)
9.2.2 Latin America HER2 Antibodies Market Size by Type (2022-2027)
9.2.3 Latin America HER2 Antibodies Market Size by Type (2016-2027)
9.3 Latin America HER2 Antibodies Market Size by Application
9.3.1 Latin America HER2 Antibodies Market Size by Application (2016-2021)
9.3.2 Latin America HER2 Antibodies Market Size by Application (2022-2027)
9.3.3 Latin America HER2 Antibodies Market Size by Application (2016-2027)
9.4 Latin America HER2 Antibodies Market Size by Country
9.4.1 Latin America HER2 Antibodies Market Size by Country (2016-2021)
9.4.2 Latin America HER2 Antibodies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa HER2 Antibodies Market Size (2016-2027)
10.2 Middle East & Africa HER2 Antibodies Market Size by Type
10.2.1 Middle East & Africa HER2 Antibodies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa HER2 Antibodies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa HER2 Antibodies Market Size by Type (2016-2027)
10.3 Middle East & Africa HER2 Antibodies Market Size by Application
10.3.1 Middle East & Africa HER2 Antibodies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa HER2 Antibodies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa HER2 Antibodies Market Size by Application (2016-2027)
10.4 Middle East & Africa HER2 Antibodies Market Size by Country
10.4.1 Middle East & Africa HER2 Antibodies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa HER2 Antibodies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis HER2 Antibodies Introduction
11.1.4 Novartis Revenue in HER2 Antibodies Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer HER2 Antibodies Introduction
11.2.4 Pfizer Revenue in HER2 Antibodies Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche HER2 Antibodies Introduction
11.3.4 Roche Revenue in HER2 Antibodies Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Abnova
11.4.1 Abnova Company Details
11.4.2 Abnova Business Overview
11.4.3 Abnova HER2 Antibodies Introduction
11.4.4 Abnova Revenue in HER2 Antibodies Business (2016-2021)
11.4.5 Abnova Recent Development
11.5 InvivoGen
11.5.1 InvivoGen Company Details
11.5.2 InvivoGen Business Overview
11.5.3 InvivoGen HER2 Antibodies Introduction
11.5.4 InvivoGen Revenue in HER2 Antibodies Business (2016-2021)
11.5.5 InvivoGen Recent Development
11.6 Celltrion
11.6.1 Celltrion Company Details
11.6.2 Celltrion Business Overview
11.6.3 Celltrion HER2 Antibodies Introduction
11.6.4 Celltrion Revenue in HER2 Antibodies Business (2016-2021)
11.6.5 Celltrion Recent Development
11.7 Biocon
11.7.1 Biocon Company Details
11.7.2 Biocon Business Overview
11.7.3 Biocon HER2 Antibodies Introduction
11.7.4 Biocon Revenue in HER2 Antibodies Business (2016-2021)
11.7.5 Biocon Recent Development
11.8 Novus Biologicals
11.8.1 Novus Biologicals Company Details
11.8.2 Novus Biologicals Business Overview
11.8.3 Novus Biologicals HER2 Antibodies Introduction
11.8.4 Novus Biologicals Revenue in HER2 Antibodies Business (2016-2021)
11.8.5 Novus Biologicals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global HER2 Antibodies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Trastuzumab
Table 3. Key Players of Lapatinib
Table 4. Key Players of Ado-trastuzumab emtansine
Table 5. Key Players of Pertuzumab
Table 6. Key Players of Everolimus
Table 7. Global HER2 Antibodies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global HER2 Antibodies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global HER2 Antibodies Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global HER2 Antibodies Market Share by Regions (2016-2021)
Table 11. Global HER2 Antibodies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global HER2 Antibodies Market Share by Regions (2022-2027)
Table 13. HER2 Antibodies Market Trends
Table 14. HER2 Antibodies Market Drivers
Table 15. HER2 Antibodies Market Challenges
Table 16. HER2 Antibodies Market Restraints
Table 17. Global HER2 Antibodies Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global HER2 Antibodies Market Share by Players (2016-2021)
Table 19. Global Top HER2 Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 Antibodies as of 2020)
Table 20. Ranking of Global Top HER2 Antibodies Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by HER2 Antibodies Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players HER2 Antibodies Product Solution and Service
Table 24. Date of Enter into HER2 Antibodies Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global HER2 Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 27. Global HER2 Antibodies Revenue Market Share by Type (2016-2021)
Table 28. Global HER2 Antibodies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global HER2 Antibodies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global HER2 Antibodies Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global HER2 Antibodies Revenue Market Share by Application (2016-2021)
Table 32. Global HER2 Antibodies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global HER2 Antibodies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America HER2 Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 35. North America HER2 Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America HER2 Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 37. North America HER2 Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America HER2 Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America HER2 Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe HER2 Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe HER2 Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe HER2 Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe HER2 Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe HER2 Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe HER2 Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific HER2 Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific HER2 Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific HER2 Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific HER2 Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific HER2 Antibodies Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific HER2 Antibodies Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America HER2 Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America HER2 Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America HER2 Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America HER2 Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America HER2 Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America HER2 Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa HER2 Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa HER2 Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa HER2 Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa HER2 Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa HER2 Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa HER2 Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 64. Novartis Company Details
Table 65. Novartis Business Overview
Table 66. Novartis HER2 Antibodies Product
Table 67. Novartis Revenue in HER2 Antibodies Business (2016-2021) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer HER2 Antibodies Product
Table 72. Pfizer Revenue in HER2 Antibodies Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Roche Company Details
Table 75. Roche Business Overview
Table 76. Roche HER2 Antibodies Product
Table 77. Roche Revenue in HER2 Antibodies Business (2016-2021) & (US$ Million)
Table 78. Roche Recent Development
Table 79. Abnova Company Details
Table 80. Abnova Business Overview
Table 81. Abnova HER2 Antibodies Product
Table 82. Abnova Revenue in HER2 Antibodies Business (2016-2021) & (US$ Million)
Table 83. Abnova Recent Development
Table 84. InvivoGen Company Details
Table 85. InvivoGen Business Overview
Table 86. InvivoGen HER2 Antibodies Product
Table 87. InvivoGen Revenue in HER2 Antibodies Business (2016-2021) & (US$ Million)
Table 88. InvivoGen Recent Development
Table 89. Celltrion Company Details
Table 90. Celltrion Business Overview
Table 91. Celltrion HER2 Antibodies Product
Table 92. Celltrion Revenue in HER2 Antibodies Business (2016-2021) & (US$ Million)
Table 93. Celltrion Recent Development
Table 94. Biocon Company Details
Table 95. Biocon Business Overview
Table 96. Biocon HER2 Antibodies Product
Table 97. Biocon Revenue in HER2 Antibodies Business (2016-2021) & (US$ Million)
Table 98. Biocon Recent Development
Table 99. Novus Biologicals Company Details
Table 100. Novus Biologicals Business Overview
Table 101. Novus Biologicals Revenue in HER2 Antibodies Business (2016-2021) & (US$ Million)
Table 102. Novus Biologicals Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HER2 Antibodies Market Share by Type: 2020 VS 2027
Figure 2. Trastuzumab Features
Figure 3. Lapatinib Features
Figure 4. Ado-trastuzumab emtansine Features
Figure 5. Pertuzumab Features
Figure 6. Everolimus Features
Figure 7. Global HER2 Antibodies Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. E-commerce Case Studies
Figure 11. HER2 Antibodies Report Years Considered
Figure 12. Global HER2 Antibodies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global HER2 Antibodies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global HER2 Antibodies Market Share by Regions: 2020 VS 2027
Figure 15. Global HER2 Antibodies Market Share by Regions (2022-2027)
Figure 16. Global HER2 Antibodies Market Share by Players in 2020
Figure 17. Global Top HER2 Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 Antibodies as of 2020
Figure 18. The Top 10 and 5 Players Market Share by HER2 Antibodies Revenue in 2020
Figure 19. Global HER2 Antibodies Revenue Market Share by Type (2016-2021)
Figure 20. Global HER2 Antibodies Revenue Market Share by Type (2022-2027)
Figure 21. North America HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America HER2 Antibodies Market Share by Type (2016-2027)
Figure 23. North America HER2 Antibodies Market Share by Application (2016-2027)
Figure 24. North America HER2 Antibodies Market Share by Country (2016-2027)
Figure 25. United States HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe HER2 Antibodies Market Share by Type (2016-2027)
Figure 29. Europe HER2 Antibodies Market Share by Application (2016-2027)
Figure 30. Europe HER2 Antibodies Market Share by Country (2016-2027)
Figure 31. Germany HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific HER2 Antibodies Market Share by Type (2016-2027)
Figure 39. Asia-Pacific HER2 Antibodies Market Share by Application (2016-2027)
Figure 40. Asia-Pacific HER2 Antibodies Market Share by Region (2016-2027)
Figure 41. China HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America HER2 Antibodies Market Share by Type (2016-2027)
Figure 49. Latin America HER2 Antibodies Market Share by Application (2016-2027)
Figure 50. Latin America HER2 Antibodies Market Share by Country (2016-2027)
Figure 51. Mexico HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa HER2 Antibodies Market Share by Type (2016-2027)
Figure 55. Middle East & Africa HER2 Antibodies Market Share by Application (2016-2027)
Figure 56. Middle East & Africa HER2 Antibodies Market Share by Country (2016-2027)
Figure 57. Turkey HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE HER2 Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Novartis Revenue Growth Rate in HER2 Antibodies Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in HER2 Antibodies Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in HER2 Antibodies Business (2016-2021)
Figure 63. Abnova Revenue Growth Rate in HER2 Antibodies Business (2016-2021)
Figure 64. InvivoGen Revenue Growth Rate in HER2 Antibodies Business (2016-2021)
Figure 65. Celltrion Revenue Growth Rate in HER2 Antibodies Business (2016-2021)
Figure 66. Biocon Revenue Growth Rate in HER2 Antibodies Business (2016-2021)
Figure 67. Novus Biologicals Revenue Growth Rate in HER2 Antibodies Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界のHER2抗体市場規模・現状・予測（2021年-2027年）

Global HER2 Antibody Market Size, Status and Forecast 2021-2027
QYR2104Z2801 2021年4月 99Pages
QYResearch社発行の本調査資料では、HER2抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（トラスツズマブ、ラパチニブ、アド-トラスツズマブエムタンシン、ペルツズマブ、エベロリムス）、用途別市場規模（病院、医療センター）、主要地域別...

世界のHER2陰性乳がん治療市場規模・現状・予測（2021年-2027年）

Global HER2-negative breast cancer Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2802 2021年4月 98Pages
QYResearch社発行の本調査資料では、HER2陰性乳がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、外科、放射線、ホルモン療法/内分泌療法）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のHER2陰性乳がん治療市場規模・現状・予測（2021年-2027年）

世界のHER2陽性進行性乳がん用モノクローナル抗体（mAb）市場規模・現状・予測（2021年-2027年）

Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size, Status and Forecast 2021-2027
QYR2104Z3903 2021年4月 93Pages
QYResearch社発行の本調査資料では、HER2陽性進行性乳がん用モノクローナル抗体（mAb）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ペルツズマブ、トラスツズマブ）、用途別市場規模（併用療法、免疫療法）、主要地域別市場規模（北米、ア...

世界のHR+/HER2-乳がん市場規模・現状・予測（2021年-2027年）

Global HR+/HER2- Breast Cancer Market Size, Status and Forecast 2021-2027
QYR2104Z2935 2021年4月 91Pages
QYResearch社発行の本調査資料では、HR+/HER2-乳がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CDK4/6阻害剤、PARP阻害剤、PI3K阻害剤、その他）、用途別市場規模（病院、がんセンター、医療研究・学術機関、外来手術セ...

世界のHER2陽性乳がん市場規模・現状・予測（2021年-2027年）

Global HER2-Positive Breast Cancer Market Size, Status and Forecast 2021-2027
QYR2104Z2803 2021年4月 129Pages
QYResearch社発行の本調査資料では、HER2陽性乳がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（グリフォラフロンドサ、手術、放射線・化学療法、内分泌療法、分子標的療法）、用途別市場規模（病院、専門クリニック、バイオテクノロジー・製...

世界のCD38モノクローナル抗体市場規模・現状・予測（2021年-2027年）

Global CD38 Monoclonal Antibodies Market Size, Status and Forecast 2021-2027
QYR2104Z1166 2021年4月 95Pages
QYResearch社発行の本調査資料では、CD38モノクローナル抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ダラツムマブ、イサツキシマブ）、用途別市場規模（薬局、実験室用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界のIVD抗体市場規模・現状・予測（2021年-2027年）

Global IVD Antibodies Market Size, Status and Forecast 2021-2027
QYR2104Z3294 2021年4月 91Pages
QYResearch社発行の本調査資料では、IVD抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（心臓マーカー、腫瘍マーカー、腎臓損傷マーカー）、用途別市場規模（病院、専門クリニック、診断センター、その他）、主要地域別市場規模（北米、アメリ...

世界の診断用特殊抗体市場規模・現状・予測（2021年-2027年）

Global Diagnostic Specialty Antibodies Market Size, Status and Forecast 2021-2027
QYR2104Z1845 2021年4月 98Pages
QYResearch社発行の本調査資料では、診断用特殊抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、ポリクローナル抗体、組換えポリクローナル抗体）、用途別市場規模（病院、診断研究所、その他）、主要地域別市場規模（北米、...

世界の診断用特殊抗体市場規模・現状・予測（2021年-2027年）

世界のHER2抗体市場規模・現状・予測（2021年-2027年） HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy. Market Analy…
世界のHER2陽性進行性乳がん用モノクローナル抗体（mAb）市場規模・現状・予測（2021年-2027年） These antibodies are used to treat metastatic (spread) breast cancer. It is effective against tumors that overexpress the HER2/neu protein. Market Analysis and Insights: Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market The global Mono-Antibody (mAb) for HER2-Positive Advanc…
世界のHER2陰性乳がん治療市場規模・現状・予測（2021年-2027年） HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein. Market Analysis and Insights: Global HER2-negative breast ca…
世界のHER2陰性乳がん治療市場規模・現状・予測（2021年-2027年） HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein. Market Analysis and Insights: Global HER2-negative breast ca…
世界のHR+/HER2-乳がん市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global HR+/HER2- Breast Cancer Market The global HR+/HER2- Breast Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…